These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31595157)

  • 1. Cathelicidin-related antimicrobial peptide protects against cardiac fibrosis in diabetic mice heart by regulating endothelial-mesenchymal transition.
    Zheng X; Peng M; Li Y; Wang X; Lu W; Wang X; Shan Y; Li R; Gao L; Qiu C
    Int J Biol Sci; 2019; 15(11):2393-2407. PubMed ID: 31595157
    [No Abstract]   [Full Text] [Related]  

  • 2. MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart.
    Liang C; Gao L; Liu Y; Liu Y; Yao R; Li Y; Xiao L; Wu L; Du B; Huang Z; Zhang Y
    Life Sci; 2019 May; 224():12-22. PubMed ID: 30872181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
    Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
    J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity.
    Yan F; Zhang GH; Feng M; Zhang W; Zhang JN; Dong WQ; Zhang C; Zhang Y; Chen L; Zhang MX
    Mol Med; 2015 Feb; 21(1):15-25. PubMed ID: 25715248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-200b Mediates Endothelial-to-Mesenchymal Transition in Diabetic Cardiomyopathy.
    Feng B; Cao Y; Chen S; Chu X; Chu Y; Chakrabarti S
    Diabetes; 2016 Mar; 65(3):768-79. PubMed ID: 26718496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
    Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
    Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
    [No Abstract]   [Full Text] [Related]  

  • 7. Saikosaponin A Protects From Pressure Overload-Induced Cardiac Fibrosis via Inhibiting Fibroblast Activation or Endothelial Cell EndMT.
    Liu Y; Gao L; Zhao X; Guo S; Liu Y; Li R; Liang C; Li L; Dong J; Li L; Yang H
    Int J Biol Sci; 2018; 14(13):1923-1934. PubMed ID: 30443195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-222 inhibits cardiac fibrosis in diabetic mice heart via regulating Wnt/β-catenin-mediated endothelium to mesenchymal transition.
    Wang Z; Wang Z; Gao L; Xiao L; Yao R; Du B; Li Y; Wu L; Liang C; Huang Z; Li P; Zhang Y
    J Cell Physiol; 2020 Mar; 235(3):2149-2160. PubMed ID: 31389030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cathelicidin-related antimicrobial peptide suppresses cardiac hypertrophy induced by pressure overload by regulating IGFR1/PI3K/AKT and TLR9/AMPKα.
    Wang X; Chen L; Zhao X; Xiao L; Yi S; Kong Y; Jiang Y; Zhang J
    Cell Death Dis; 2020 Feb; 11(2):96. PubMed ID: 32029708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy.
    Liu X; Mujahid H; Rong B; Lu QH; Zhang W; Li P; Li N; Liang ES; Wang Q; Tang DQ; Li NL; Ji XP; Chen YG; Zhao YX; Zhang MX
    J Cell Mol Med; 2018 Feb; 22(2):808-822. PubMed ID: 29063670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effects of Eicosapentaenoic Acid on the Glomerular Endothelium via Inhibition of EndMT in Diabetes.
    Yasuzawa T; Nakamura T; Ueshima S; Mima A
    J Diabetes Res; 2021; 2021():2182225. PubMed ID: 34977254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tectorigenin protects against cardiac fibrosis in diabetic mice heart via activating the adiponectin receptor 1-mediated AMPK pathway.
    Ma YL; Xu M; Cen XF; Qiu HL; Guo YY; Tang QZ
    Biomed Pharmacother; 2024 May; 174():116589. PubMed ID: 38636400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial cell metabolic memory causes cardiovascular dysfunction in diabetes.
    Yao Y; Song Q; Hu C; Da X; Yu Y; He Z; Xu C; Chen Q; Wang QK
    Cardiovasc Res; 2022 Jan; 118(1):196-211. PubMed ID: 33483741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mangiferin alleviates diabetic pulmonary fibrosis in mice via inhibiting endothelial-mesenchymal transition through AMPK/FoxO3/SIRT3 axis.
    Fu TL; Li GR; Li DH; He RY; Liu BH; Xiong R; Xu CZ; Lu ZL; Song CK; Qiu HL; Wang WJ; Zou SS; Yi K; Li N; Geng Q
    Acta Pharmacol Sin; 2024 May; 45(5):1002-1018. PubMed ID: 38225395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Interaction of Apelin and FGFR1 Ameliorated the Kidney Fibrosis through Suppression of TGF
    Gao R; Wu Y; Yang Q; Chen L; Chen J; Wang B; Liu Z; Jin J; Li J; Wu G
    Oxid Med Cell Longev; 2023; 2023():5012474. PubMed ID: 36785790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway.
    Geng H; Guan J
    Biochem Biophys Res Commun; 2017 Sep; 491(2):329-336. PubMed ID: 28733035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice.
    Li J; Liu H; Srivastava SP; Hu Q; Gao R; Li S; Kitada M; Wu G; Koya D; Kanasaki K
    Hypertension; 2020 Dec; 76(6):1935-1944. PubMed ID: 33131311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3.
    Sharma V; Dogra N; Saikia UN; Khullar M
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1263-1270. PubMed ID: 28686848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan inhibits endothelial-to-mesenchymal transformation in mitral valve endothelial cells by blocking transforming growth factor-β-induced phosphorylation of ERK.
    Wylie-Sears J; Levine RA; Bischoff J
    Biochem Biophys Res Commun; 2014 Apr; 446(4):870-5. PubMed ID: 24632204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRC5 deficiency ameliorates cardiac fibrosis in diabetic cardiomyopathy by regulating EndMT through Smad2/3 signaling pathway.
    Wang B; Wu Y; Ge Z; Zhang X; Yan Y; Xie Y
    Biochem Biophys Res Commun; 2020 Jul; 528(3):545-553. PubMed ID: 32505342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.